Providing investors with the opportunity to participate in the growth of a diversified portfolio of innovative and emerging Beverages Brands
NYSE: $SBEV
This is exactly the direction Splash believes the market is heading. As regulatory clarity continues to improve, the intersection of wellness, healthcare, and consumer access represents a significant opportunity.
$SBEV is positioning accordingly.
$SBEV Rescheduling cannabis is a long-overdue correction that aligns with core American principles—freedom and states’ rights. As cannabis continues to intersect with healthcare and wellness—including emerging federal programs—modernizing its classification is essential. Onward
We believe this evolving regulatory posture underscores the growing role of cannabinoids within mainstream wellness. Our recently announced LOI with Medterra reflects our focus on building a scalable, compliant platform positioned for this shift. #Wellness#Cannabinoids $SBEV
This is the first time a federal agency has waived enforcement and/or expressly indicated it will not take action regarding cannabinoids. Also note the nutraceutical angle. Game on!!! $SBEV x Medterra
A lot is happening at $SBEV, Our latest shareholder letter covers key developments including:
· Reverse stock split & trading resumption
· Strengthening leadership with new CFO & director
SBG is taking bold steps to drive growth and unlock long-term value. Read the full update here
https://t.co/mDmJxYSZ6c